Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Natco Pharma Mekaguda facility gets EIR from USFDA

      Natco Pharma Mekaguda facility gets EIR from USFDA

      Farhat Nasim1 Oct 2019 3:57 PM IST
      Hyderabad: Drug firm Natco Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Active...
      Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

      Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

      Farhat Nasim1 Oct 2019 2:13 PM IST
      The company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
      Setback: AstraZeneca fails to win USFDA nod for combo lung disease therapy

      Setback: AstraZeneca fails to win USFDA nod for combo lung disease therapy

      Farhat Nasim1 Oct 2019 10:00 AM IST
      The setback comes as AstraZeneca tries to catch up with domestic rival GlaxoSmithKline's Trelegy, which is delivered through inhaler Ellipta. That...
      Glenmark wins Russian Health Ministry nod for allergic rhinitis drug Montlezir

      Glenmark wins Russian Health Ministry nod for allergic rhinitis drug Montlezir

      Farhat Nasim30 Sept 2019 3:29 PM IST
      Glenmark Pharma's allergic rhinitis drug Montlezir is expected to be available in the Russian market in Q3 FY 2019‐20.Mumbai: Glenmark Pharmaceuticals...
      Health Ministry reprimands CDSCO officers for frequent visit to ministry office

      Health Ministry reprimands CDSCO officers for frequent visit to ministry office

      Farhat Nasim29 Sept 2019 12:30 PM IST
      All CDSCO officers have been accordingly advised by the Health Ministry via the circular to be careful and not to visit the Ministry except on being...
      CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

      CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

      Farhat Nasim25 Sept 2019 1:19 PM IST
      New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
      13 medical outlets violate provisions of Drugs and Cosmetics Act, licenses suspended

      13 medical outlets violate provisions of Drugs and Cosmetics Act, licenses suspended

      Farhat Nasim25 Sept 2019 9:00 AM IST
      Licenses of the erring establishments -- five in Jammu city, three at Bari Brahmna and five at R S Pura -- were suspended for violating provisions of...
      Biocon acquires Pfizer RnD facility to boost biosimilars portfolio

      Biocon acquires Pfizer RnD facility to boost biosimilars portfolio

      Farhat Nasim24 Sept 2019 3:44 PM IST
      Biocon Biologics has acquired Research and Development(RnD) capital assets from Pfizer Healthcare India Ltd.New Delhi: Biopharmaceuticals company,...
      SEBI slaps fine of Rs 22 crore on Aurobindo Pharma, promoters for insider trading

      SEBI slaps fine of Rs 22 crore on Aurobindo Pharma, promoters for insider trading

      Farhat Nasim24 Sept 2019 12:00 PM IST
      The probe found that the promoter entities traded in the scrip of APL based on unpublished price sensitive information or UPSI pertaining to Aurobindo...
      Laurus Labs to acquire subsidiary of ASPEN Pharmacare

      Laurus Labs to acquire subsidiary of ASPEN Pharmacare

      Farhat Nasim24 Sept 2019 9:30 AM IST
      "The completion of conditions precedent, by way of cash consideration of ZAR 75,000, the Pharmaceutical company said in a statement here. The...
      Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

      Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

      Farhat Nasim23 Sept 2019 5:46 PM IST
      New Delhi: The Drugs Consultative Committee (DCC), functional under Central Drugs Standard Control Organisation (CDSCO), recently recommended the...
      Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

      Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

      Farhat Nasim21 Sept 2019 3:21 PM IST
      The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok